“According to the research report, the global irritable bowel syndrome (IBS) treatment market was valued at USD 3.69 billion in 2023 and is expected to reach USD 7.60 billion by 2032, to grow at a CAGR of 8.4% during the forecast period.”
Polaris Market Research, a leading global market research firm, has announced the release of its latest report on the rapidly...
English
Arabic
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian